Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Putrescine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Putrescine SCHEMBL29458 | 1.00 | — | — | |
| Putrescine SCHEMBL7870217 | 1.00 | NFKB1 (0.88) | — | |
| Diaminooctane SCHEMBL11590021 | 0.94 | DNM1 (0.89) | — | |
| Hydrochloric Acid SCHEMBL11097203 | 0.94 | DNM1 (0.89) | — | |
| Putrescine SCHEMBL5060928 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL9460262 | 0.94 | DNM1 (0.89) | — | |
| Hydrochloric Acid SCHEMBL344248 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL2105217 | 0.94 | DNM1 (0.89) | — | |
| Hydrochloric Acid SCHEMBL9129810 | 0.94 | DNM1 (0.89) | — | |
| Hydrochloric Acid SCHEMBL284928 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 464 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119907609-A | Solar cell, preparation method thereof, electric equipment and power generation equipment | 天合光能股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119709597-A | Serum-free culture medium and culture method for industrial production of human erythropoietin | 深圳未名新鹏生物医药有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119662528-A | In-vitro suspension culture medium and preparation method thereof | 北京阿尔法拜欧生物科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119391806-A | Method for identifying compound for inhibiting synthesis of vomitoxin of wheat stem rot pathogen | 安徽农业大学 | 2025-02-07 | — | — | CN | claimed |
| CN-119351067-A | Solid slow-release acid for offshore oilfield blocking removal operation and preparation method thereof | 中海石油（中国）有限公司天津分公司 | 2025-01-24 | — | — | CN | claimed |
| CN-115896002-B | Culture medium and culture method for amplifying adult lung stem cells of mice | 中国医学科学院生物医学工程研究所 | 2024-12-27 | — | — | CN | claimed |
| CN-119023636-A | Method and system for monitoring chloride ions of concrete | 中交四航局第一工程有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-117683715-A | Method for preparing type I NKT cells by using umbilical cord blood | 博雅干细胞科技有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-117562924-A | External Zhou Xieyuan inKT cell, preparation method thereof and application thereof in leukemia | 博雅干细胞科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-116904357-A | Strain capable of tolerating high-concentration 1,4-butanediamine as well as culture method and application thereof | 天津科技大学 | 2023-10-20 | — | — | CN | claimed |
| CN-107155623-A | A kind of prevention and control flue-cured tobacco high temperature forces ripe cultural method | 郑州大学 | 2017-09-15 | — | — | CN | claimed |
| CN-107136552-A | A kind of flue-cured tobacco high temperature forces ripe prevention and control agent and its application | 中国烟草总公司湖南省公司 | 2017-09-08 | — | — | CN | claimed |
| CN-105779376-A | Serum-free medium for separating influenza viruses and purpose and preparation method thereof | 友康恒业生物科技（北京）有限公司 | 2016-07-20 | — | — | CN | claimed |
| CN-105695393-A | MDCK cell serum-free culture medium and purpose and preparation thereof | 友康恒业生物科技（北京）有限公司 | 2016-06-22 | — | — | CN | claimed |
| CN-104877961-A | Serum-free human amniotic mesenchymal stem cell culture medium and preparation method thereof | GUANGZHOU SAILAI STEMCELL SCIENCE AND TECHNOLOGY CO LTD | 2015-09-02 | — | — | CN | claimed |
| US-7537885-B2 | Composition for maintaining organ and cell viability | LIFEBLOOD MEDICAL INC. (US) | 2009-05-26 | — | — | US | claimed |
| US-20070178435-A1 | COMPOSITION FOR MAINTAINING ORGAN AND CELL VIABILITY | LIFEBLOOD MEDICAL, INC. (US) | 2007-08-02 | — | — | US | claimed |
| US-7220538-B2 | Composition for maintaining organ and cell viability | LIFEBLOOD MEDICAL, INC. (US) | 2007-05-22 | — | — | US | claimed |
| US-20050037330-A1 | Composition for maintaining organ and cell viability | NEW GROVE INVESTMENTS, INC. | 2005-02-17 | — | — | US | claimed |
| US-5326699-A | Serum-free medium for culturing animal cells | KURASHIKI BOSEKI KABUSHIKI KAISHA (JP) | 1994-07-05 | — | — | US | claimed |